Beware of the biologicals--hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1951-2010).
The first patient entered the Rheumatism Foundation Hospital, Heinola, Finland in July 1951. From that point on, the hospital helped patients suffering from rheumatic disorders. Specialists in the hospital actively developed treatments and published a large number of scientific articles in international journals. The hospital was well known internationally among people working in the field. Progress in the development of disease-modifying medication (biological agents in particular) has dramatically improved the life of patients with rheumatic diseases, but all effective treatments may also have adverse effects. In this article, we briefly review the history of the Rheumatism Foundation Hospital, which was closed permanently in March 2010 due to bankruptcy. The economical difficulties were caused primarily by the progress made in disease-modifying therapy, which decreased the need of rehabilitation and operative treatment of patients with rheumatic diseases. It seems that a great success in biological agents can carry "serious adverse effects", which may kill hospitals. This is an important primary observation, which should be noticed when the future of specialised institutes is planned.
Department of Rheumatology, Päijät-Häme Central Hospital, Keskussairaalankatu 7, 15850 Lahti, Finland. markku.kauppi@phsotey.fi
Markku J
MJ
Kauppi
Hanna
H
Säilä
Eero A
EA
Belt
Markku
M
Hakala
D001688:Biological Products / Q000266:history* / Q000627:therapeutic use; D004469:Economics, Hospital; D005387:Finland; D049673:History, 20th Century; D049674:History, 21st Century; D006782:Hospitals, Special / Q000266:history*; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000266:history*
D001688:Biological Products